Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06CVT
|
|||
| Former ID |
DAP001528
|
|||
| Drug Name |
Tianeptine
|
|||
| Synonyms |
Tianeptina; Tianeptinum; Tianeptine Acid; Tianeptine [INN]; Stablon (TN); Tianeptine (INN); (1)-7-((3-Chloro-6,11-dihydro-6-methyldibenzo(c,f)(1,2)thiazepin-11-yl)amino)heptanoic acid S,S-dioxide; 7-[(3-chloro-6-methyl-5,5-dioxido-6,11-dihydrodibenzo[c,f][1,2]thiazepin-11-yl)amino]heptanoic acid; 7-[(3-chloro-6-methyl-5,5-dioxo-11H-benzo[c][2,1]benzothiazepin-11-yl)amino]heptanoic acid
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Major depressive disorder [ICD-11: 6A70.3; ICD-10: F32.2] | Approved | [1], [2], [3] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C21H25ClN2O4S
|
|||
| Canonical SMILES |
CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)O
|
|||
| InChI |
1S/C21H25ClN2O4S/c1-24-18-9-6-5-8-16(18)21(23-13-7-3-2-4-10-20(25)26)17-12-11-15(22)14-19(17)29(24,27)28/h5-6,8-9,11-12,14,21,23H,2-4,7,10,13H2,1H3,(H,25,26)
|
|||
| InChIKey |
JICJBGPOMZQUBB-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 72797-41-2
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
6243297, 8192407, 14930306, 17396746, 43125383, 49834577, 57317121, 78806126, 85175447, 91616270, 92719757, 99381468, 104343282, 117461940, 118844741, 123087233, 125355861, 126620557, 126655743, 126669538, 128278297, 131323118, 134338709, 135204769, 135259984, 137172964, 142970937, 152040009, 152258933, 160647777, 162178730, 163068340, 164234531, 164765590, 164814565, 177748539, 179226145, 185990403, 187072591, 211536271, 223365894, 223387136, 223678309, 223704753, 224381628, 226433082, 242455962, 252357546, 252357547, 252424765
|
|||
| ChEBI ID |
CHEBI:91749
|
|||
| SuperDrug ATC ID |
N06AX14
|
|||
| SuperDrug CAS ID |
cas=066981735
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Serotonin transporter (SERT) | Target Info | Inhibitor | [2] |
| KEGG Pathway | Serotonergic synapse | |||
| NetPath Pathway | TCR Signaling Pathway | |||
| Panther Pathway | 5HT1 type receptor mediated signaling pathway | |||
| 5HT2 type receptor mediated signaling pathway | ||||
| 5HT3 type receptor mediated signaling pathway | ||||
| 5HT4 type receptor mediated signaling pathway | ||||
| WikiPathways | Monoamine Transport | |||
| SIDS Susceptibility Pathways | ||||
| NRF2 pathway | ||||
| Synaptic Vesicle Pathway | ||||
| Serotonin Transporter Activity | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7558). | |||
| REF 2 | Emerging treatments for depression. Expert Opin Pharmacother. 2006 Dec;7(17):2323-39. | |||
| REF 3 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.